Curis Lifesciences
Listed
Listed
IPO Timeline
Issue open date
7 Nov 2025Issue close date
11 Nov 2025UPI mandate deadline
11 Nov 2025Allotment finalization
12 Nov 2025Refund initiation
13 Nov 2025Share credit
13 Nov 2025Listing date
14 Nov 2025Mandate end date
26 Nov 2025Lock-in end date for anchor investors (50%)
12 Dec 2025Lock-in end date for anchor investors (remaining)
10 Feb 2026Grey Market Premium Trend
₹9
Current GMP
₹137
Est. Listing Price
7.0%
Est. Listing Gain
₹120 - ₹128
Price Band
GMP History
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 13 Nov | ₹9 | ₹137 | 7.03% |
| 12 Nov | ₹9 | ₹137 | 7.03% |
| 11 Nov | ₹9 | ₹137 | 7.03% |
| 10 Nov | ₹6 | ₹134 | 4.69% |
| 9 Nov | ₹8 | ₹136 | 6.25% |
| 8 Nov | ₹8 | ₹136 | 6.25% |
| 7 Nov | ₹8 | ₹136 | 6.25% |
| 6 Nov | ₹8 | ₹136 | 5.86% |
| 5 Nov | ₹8 | ₹136 | 5.86% |
| 4 Nov | ₹6 | ₹134 | 4.69% |
| 3 Nov | ₹0 | ₹128 | 0.00% |
| 2 Nov | ₹0 | ₹128 | 0.00% |
| 31 Oct | ₹0 | ₹128 | 0.00% |
| 30 Oct | ₹0 | ₹128 | 0.00% |
Key Dates
Open
7 Nov 2025Close
11 Nov 2025Listing
14 Nov 2025Quick Stats
Issue Size:28cr
Lot Size:1000 shares
About the Company
Curis Lifesciences Limited began as “M/s Loreto Pharmaceuticals,” a partnership firm founded in 2010, engaged in marketing and trading pharma products. The company specializes in the manufacturing of tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments.
Strengths
- Strong brand recognition through “Mufti”, a leading casual menswear label.
- Wide distribution network across 600+ stores and 1,400+ multi-brand outlets.
- Focused product strategy targeting youthful, urban customers with competitive pricing.
- Asset-light model with third-party manufacturing keeps operating costs low.
- Experienced leadership driving steady growth in sales and profitability.
Risks
- High dependence on third-party manufacturers for product quality and timelines.
- Intense competition from established apparel brands and fast-fashion players.
- Reliance on India’s discretionary spending trends, vulnerable to economic slowdown.
- No long-term contracts with suppliers and distributors may disrupt supply chains.
Curis Lifesciences IPO – Frequently Asked Questions
- The price band for the Curis Lifesciences IPO is set at ₹120 to ₹128 per share.
- The Curis Lifesciences IPO opens on November 7, 2025 and closes on November 11, 2025.
- The tentative listing date for the Curis Lifesciences IPO is November 14, 2025.
- You can apply for the Curis Lifesciences IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Curis Lifesciences, enter lot quantity and UPI ID, then approve the mandate.
- The lot size for the Curis Lifesciences IPO is 1000 shares. Investors must apply for at least one lot (i.e., 1000 shares).